| Typicality: | 0.711 |
| Saliency: | 0.904 |
| during the second and third trimesters | 27 | temporal |
| ace inhibitor → be used in → pregnancy | 30 |
| ace inhibitor → be administered to → pregnant women | 17 |
| negative | neutral | positive |
| 0.912 | 0.085 | 0.003 |
| Raw frequency | 47 |
| Normalized frequency | 0.904 |
| Modifier score | 1.000 |
| Perplexity | 166.136 |